Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Gilead advances ADC dreams with potential $465M deal
Gilead is paying Munich-based biotech Tubulis $20M upfront, with the chance of a $30M option and up to $415M in milestone payments.
Darren Incorvaia
Dec 3, 2024 10:54am
BMS taps AI Proteins in drug discovery collab worth up to $400M
Dec 3, 2024 10:45am
Janux's T-cell engager makes waves, again, with new data drop
Dec 3, 2024 11:40am
Maze finds its way to $115M series D
Dec 3, 2024 12:42pm
Elevar offers $500M biobucks for Relay's rare cancer asset
Dec 3, 2024 3:04pm
Compounds from bog fungi kill tuberculosis bacteria in the lab
Dec 3, 2024 2:00pm
Medtech News
Philips, Mayo Clinic team up on AI for cardiac MRI scans
Dec 3, 2024 1:30pm
Siemens Healthineers debuts automated abdomen ultrasound AI
Dec 3, 2024 12:00pm
GE HealthCare to take over Japanese radiopharmaceutical venture
Dec 2, 2024 2:00pm
Novocure's TTFields clear phase 3 pancreatic cancer trial
Dec 2, 2024 11:30am
See More Medtech News